Amoéba An amoebalicious adventure from fungus fighters to wrinkle warriors
We initiate coverage on Amoéba, an industrial biotechnology company based in Chassieu, France, that focuses on innovative uses of the amoeba Willaertia magna C2c Maky. The company aims to become a major player in the global biocontrol market for plant protection as well as the cosmetics market. Based on a DCF/SOTP analysis, we issue a € 1.7 TP and Buy rating.Amoeba SA. Amoeba SA is a France-based company that develops, manufactures and markets biological products. The Company specializes in disruptive biological solutions for the treatment of Legionella, amoeba and biofilm in water. The Company's offering includes products and services, such as: Cleantech biological solution, a patented technological disruptive product with no impact on the environment; amoebic analyses of waters of wet cooling towers (TAR), hot sanitary waters, industrial waters and waters of swimming pools; as well as Legionella tests of industrial waste water, among others. The Company is engaged in various technical, commercial, industrial and investment partnerships.
We are a financial services provider for several types of professional clients, each with distinct needs.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.